Brown CE - Search Results

1

Optimization of IL13Rα2-Targeted Chimeric Antigen Receptor T Cells for Improved Anti-tumor Efficacy against Glioblastoma.

Brown CE, Aguilar B, Starr R, Yang X, Chang WC, Weng L, Chang B, Sarkissian A, Brito A, Sanchez JF, Ostberg JR, D'Apuzzo M, Badie B, Barish ME, Forman SJ. Brown CE, et al. Mol Ther. 2018 Jan 3;26(1):31-44. doi: 10.1016/j.ymthe.2017.10.002. Epub 2017 Oct 5. Mol Ther. 2018. PMID: 29103912 Free PMC article.

2

Specific recognition and killing of glioblastoma multiforme by interleukin 13-zetakine redirected cytolytic T cells.

Kahlon KS, Brown C, Cooper LJ, Raubitschek A, Forman SJ, Jensen MC. Kahlon KS, et al. Cancer Res. 2004 Dec 15;64(24):9160-6. doi: 10.1158/0008-5472.CAN-04-0454. Cancer Res. 2004. PMID: 15604287

3

Biophotonic cytotoxicity assay for high-throughput screening of cytolytic killing.

Brown CE, Wright CL, Naranjo A, Vishwanath RP, Chang WC, Olivares S, Wagner JR, Bruins L, Raubitschek A, Cooper LJ, Jensen MC. Brown CE, et al. J Immunol Methods. 2005 Feb;297(1-2):39-52. doi: 10.1016/j.jim.2004.11.021. Epub 2005 Jan 22. J Immunol Methods. 2005. PMID: 15777929

4

T-cell genetic modification for re-directed tumor recognition.

Cooper LJ, Kalos M, DiGiusto D, Brown C, Forman SJ, Raubitschek A, Jensen MC. Cooper LJ, et al. Cancer Chemother Biol Response Modif. 2005;22:293-324. doi: 10.1016/s0921-4410(04)22014-2. Cancer Chemother Biol Response Modif. 2005. PMID: 16110618 Review. No abstract available.

5

Conversion of a tumor-binding peptide identified by phage display to a functional chimeric T cell antigen receptor.

Pameijer CR, Navanjo A, Meechoovet B, Wagner JR, Aguilar B, Wright CL, Chang WC, Brown CE, Jensen MC. Pameijer CR, et al. Among authors: brown ce. Cancer Gene Ther. 2007 Jan;14(1):91-7. doi: 10.1038/sj.cgt.7700993. Epub 2006 Oct 6. Cancer Gene Ther. 2007. PMID: 17024231

6

Tumor-derived chemokine MCP-1/CCL2 is sufficient for mediating tumor tropism of adoptively transferred T cells.

Brown CE, Vishwanath RP, Aguilar B, Starr R, Najbauer J, Aboody KS, Jensen MC. Brown CE, et al. J Immunol. 2007 Sep 1;179(5):3332-41. doi: 10.4049/jimmunol.179.5.3332. J Immunol. 2007. PMID: 17709550

7

Medulloblastomas expressing IL13Ralpha2 are targets for IL13-zetakine+ cytolytic T cells.

Stastny MJ, Brown CE, Ruel C, Jensen MC. Stastny MJ, et al. Among authors: brown ce. J Pediatr Hematol Oncol. 2007 Oct;29(10):669-77. doi: 10.1097/MPH.0b013e3181468c68. J Pediatr Hematol Oncol. 2007. PMID: 17921847

8

Recognition and killing of brain tumor stem-like initiating cells by CD8+ cytolytic T cells.

Brown CE, Starr R, Martinez C, Aguilar B, D'Apuzzo M, Todorov I, Shih CC, Badie B, Hudecek M, Riddell SR, Jensen MC. Brown CE, et al. Cancer Res. 2009 Dec 1;69(23):8886-93. doi: 10.1158/0008-5472.CAN-09-2687. Epub 2009 Nov 10. Cancer Res. 2009. PMID: 19903840 Free PMC article.

9

Sorafenib induces growth arrest and apoptosis of human glioblastoma cells through the dephosphorylation of signal transducers and activators of transcription 3.

Yang F, Brown C, Buettner R, Hedvat M, Starr R, Scuto A, Schroeder A, Jensen M, Jove R. Yang F, et al. Mol Cancer Ther. 2010 Apr;9(4):953-62. doi: 10.1158/1535-7163.MCT-09-0947. Epub 2010 Apr 6. Mol Cancer Ther. 2010. PMID: 20371721 Free PMC article.

10

Induction of anti-glioma natural killer cell response following multiple low-dose intracerebral CpG therapy.

Alizadeh D, Zhang L, Brown CE, Farrukh O, Jensen MC, Badie B. Alizadeh D, et al. Among authors: brown ce. Clin Cancer Res. 2010 Jul 1;16(13):3399-408. doi: 10.1158/1078-0432.CCR-09-3087. Epub 2010 Jun 22. Clin Cancer Res. 2010. PMID: 20570924 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

551 results

Search Page

Filters